Biography of Andrew Cheng
Last update: December 22, 2023Career
Andrew was President and Chief Executive Officer at Akero Therapeutics, and Chief Medical Officer and Executive Vice President at Gilead Sciences.
Andrew Cheng is currently- Director, President and Chief Executive Officer at Akero Therapeutics - View - Akero Therapeutics org chart
- Director at Vera Therapeutics - View - Vera Therapeutics org chart
- Member of the Supervisory Board at Morphosys - View - Morphosys org chart
Create your alert
to follow the career of Andrew Cheng.
Education
Andrew Cheng has a PhD in Cellular and Molecular Biology from Columbia University College of Physicians and Surgeon and an Internal Medicine Residency from University of California, Los Angeles.
They have also studied at University of California, Los Angeles :
Find more alumni from University of California, Los Angeles
More about Andrew Cheng
Selected links
Do you need to know more about Andrew Cheng? More results.
Participate
Social media
- Andrew Cheng on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Andrew Cheng
The colleagues of Andrew Cheng
Company Colleagues
- At Akero Therapeutics, Andrew Cheng has 14 colleagues including Graham Walmsley (Director), Tom Heyman (Director)…
- At Vera Therapeutics, Andrew Cheng has 18 colleagues including Marshall Fordyce (CEO & Director), Maha Katabi (Director)…
- At Morphosys, Andrew Cheng has 24 colleagues including Jean-Paul Kress (CEO), George Golumbeski (Vice Chairman of the Board)…
Homonyms
- Andrew Cheng - Group Human Resources Director - Hutchison Port
- Andrew Cheng - Head of Global Procurement and Logistics - Laird Performance Materials
Industry Colleagues
- In the Biotechnology industry, Andrew Cheng has 30,227 colleagues in 2,280 companies located in 40 countries. 14,408 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Andrew Cheng.
Get in Touch
and ask for Andrew Cheng.
